IQV

SEC source: 0001144204-17-030523 · v468178_4.xml · nonDerivative · entry 3

CPP Investment Board Private Holdings, Inc. · CIK 0001604687 · 10% owner

CANADA PENSION PLAN INVESTMENT BOARD · CIK 0001283718 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,569,600

F3 · ownership.direct: The disposed securities reported on this row reflect a disposition of indirect ownership by CPPIB as a result of the disposition of 2,377,055 shares of the issuer by CPPIB-PHI. CPPIB directly owns 1,569,600 shares of the issuer and the disposed securities reported on this Form 4 do not include any securities directly owned by CPPIB. CPPIB-PHI has no beneficial ownership over the issuer's securities that are directly owned by CPPIB.

SEC source: 0001144204-17-030523 · v468178_4.xml · nonDerivative · entry 2

CPP Investment Board Private Holdings, Inc. · CIK 0001604687 · 10% owner

CANADA PENSION PLAN INVESTMENT BOARD · CIK 0001283718 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 15,468,826

F2 · ownership.nature: The securities reported on this row are indirectly owned by Canada Pension Plan Investment Board ("CPPIB") and consist of (i) 15,462,226 shares of the issuer directly owned by CPPIB-PHI, a wholly-owned subsidiary of CPPIB, and (ii) 6,600 shares of the issuer owned by CPPIB MAP Cayman SPC, a wholly-owned subsidiary of CPPIB. CPPIB-PHI has no beneficial ownership over the 6,600 shares of common stock held indirectly by CPPIB through CPPIB MAP Cayman SPC.

SEC source: 0001144204-17-030523 · v468178_4.xml · nonDerivative · entry 1

CPP Investment Board Private Holdings, Inc. · CIK 0001604687 · 10% owner

CANADA PENSION PLAN INVESTMENT BOARD · CIK 0001283718 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,462,226

F1 · ownership.direct: The securities reported on this row are directly owned by CPP Investment Board Private Holdings, Inc. ("CPPIB-PHI").

SEC source: 0000903423-17-000408 · quintiles.xml · nonDerivative · entry 1

TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · Director · 10% owner

TPG Advisors VI, Inc. · CIK 0001433038 · Director · 10% owner

TPG Advisors V, Inc. · CIK 0001425876 · Director · 10% owner

TPG Biotech Advisors, Inc. · CIK 0001666545 · Director · 10% owner

BONDERMAN DAVID · CIK 0000860866 · Director · 10% owner

COULTER JAMES G · CIK 0001099776 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 36,935,608

F1 · ownership.nature: David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. ("Group Advisors"), (ii) TPG Advisors VI, Inc. ("Advisors VI"), (iii) TPG Advisors V, Inc. ("Advisors V") and (iv) TPG Biotech Advisors, Inc. ("Biotech Advisors" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the "Reporting Persons").

F2 · ownership.nature: Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 13,208,160 shares of Common Stock ("Common Stock") of Quintiles IMS Holdings, Inc. (the "Issuer"), (ii) TPG FOF V-A, L.P., which directly holds 34,553 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 27,861 shares of Common Stock.

F3 · ownership.nature: TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 13,218,321 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 545,366 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 52,252 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 4,544,717 shares of Common Stock.

F4 · ownership.nature: Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 5,040,614 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the "TPG Funds"), which directly holds 263,764 shares of Common Stock.

F5 · ownership.nature: Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any.

F6 · ownership.nature: The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the "Shareholders Agreement"), with certain other holders (the "Holders") of shares of Common Stock. Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), to beneficially own the shares of Common Stock held in the aggregate by the Holders. Each Reporting Person and each TPG Fund disclaims beneficial ownership of the shares of Common Stock held by the Holders.

F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

SEC source: 0000899243-17-015144 · doc4.xml · nonDerivative · entry 1

CONNAUGHTON JOHN · CIK 0001213395 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 8,726,148

F1 · ownership.nature: Represents shares of Common Stock held directly by Bain Capital Integral Investors 2008, L.P., BCIP TCV, LLC and BCIP Associates-G (collectively, the "Bain Capital Entities).

F2 · ownership.nature: The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Entities is directed by the Global Private Equity Board ("GPEB") of Bain Capital Investors, LLC ("BCI"). John Connaughton is a member of GPEB and a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001209191-17-036619 · doc4.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 5,453,659

F1 · shares: 581,251 shares of common stock, par value $0.01 per share, of the Issuer (the "Shares") were sold by Green Equity Investors V, L.P. ("GEI V"), 174,361 Shares were sold by Green Equity Investors Side V, L.P. ("GEI Side V"), and 5,531 Shares were sold by LGP Iceberg Coinvest, LLC ("LGP Ice").

F2 · balance_after: 4,164,715 Shares are owned by GEI V, 1,249,314 Shares are owned by GEI Side V, and 39,630 Shares are owned by LGP Ice. The Shares reported on this row are subject to a lock-up agreement and cannot be sold without underwriter consent until 45 days after the date of the prospectus relating to the transactions reported hereon.

F3 · ownership.nature: Mr. Danhakl directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares owned by GEI V, GEI Side V, and LGP Ice. Mr. Danhakl disclaims beneficial ownership of the Shares reported herein except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-17-014545 · doc4.xml · nonDerivative · entry 1

CONNAUGHTON JOHN · CIK 0001213395 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 9,813,934

F3 · kind: On May 24, 2017, the Bain Capital Entities distributed 130,083 shares of Common Stock to one or more members or partners of the Bain Capital Entities in connection with certain charitable gifts made by such members or partners on May 24, 2017.

F1 · ownership.nature: Represents shares of Common Stock held directly by Bain Capital Integral Investors 2008, L.P., BCIP TCV, LLC and BCIP Associates-G (collectively, the "Bain Capital Entities).

F2 · ownership.nature: The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Entities is directed by the Global Private Equity Board ("GPEB") of Bain Capital Investors, LLC ("BCI"). John Connaughton is a member of GPEB and a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001478242-17-000031 · edgar.xml · nonDerivative · entry 1

GREENBERG JACK M · CIK 0001074611 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,316

F1 · shares: Shares acquired from award of Quintiles IMS Holdings, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

SEC source: 0001478242-17-000034 · edgar.xml · derivative · entry 1

Parks Robert · CIK 0001707662 · Sr Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,487

Underlying: Common Stock · 2,487 shares

Expires 2027-05-23

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 05/23/2018.

SEC source: 0001478242-17-000030 · edgar.xml · nonDerivative · entry 1

LEONARD JOHN M. · CIK 0001563584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,702

F1 · shares: Shares acquired from award of Quintiles IMS Holdings, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

SEC source: 0001478242-17-000029 · edgar.xml · nonDerivative · entry 1

EVANISKO MICHAEL J · CIK 0001258567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,732

F1 · shares: Shares acquired from award of Quintiles IMS Holdings, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

SEC source: 0001478242-17-000028 · edgar.xml · nonDerivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,235

F1 · shares: Shares acquired from award of Quintiles IMS Holdings, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

SEC source: 0001478242-17-000017 · edgar.xml · derivative · entry 4

GREENBERG JACK M · CIK 0001074611 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 6,092 shares

Expires 2018-06-01

F1 · ownership.nature: The shares are held for the benefit of members of the reporting person's family. The reporting person may be deemed to have voting and dispositive power over the shares held for the benefit of members of his family. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001478242-17-000017 · edgar.xml · nonDerivative · entry 2

GREENBERG JACK M · CIK 0001074611 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 25,000

F1 · ownership.nature: The shares are held for the benefit of members of the reporting person's family. The reporting person may be deemed to have voting and dispositive power over the shares held for the benefit of members of his family. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001478242-17-000017 · edgar.xml · nonDerivative · entry 1

GREENBERG JACK M · CIK 0001074611 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 31,092

F1 · ownership.nature: The shares are held for the benefit of members of the reporting person's family. The reporting person may be deemed to have voting and dispositive power over the shares held for the benefit of members of his family. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001478242-17-000015 · edgar.xml · nonDerivative · entry 1

Erlinger III James H · CIK 0001575957 · Exec VP and GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,340

SEC source: 0001478242-17-000012 · edgar.xml · nonDerivative · entry 2

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,321

SEC source: 0001478242-17-000013 · edgar.xml · nonDerivative · entry 2

Williams Charles Edward · CIK 0001376911 · Sr VP and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,494

SEC source: 0001478242-17-000012 · edgar.xml · nonDerivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,413

SEC source: 0001478242-17-000013 · edgar.xml · nonDerivative · entry 1

Williams Charles Edward · CIK 0001376911 · Sr VP and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,586

SEC source: 0001209191-17-015818 · doc4.xml · nonDerivative · entry 1

GILLINGS DENNIS B PH D · CIK 0000939158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,862,230

SEC source: 0000903423-17-000161 · quintiles.xml · nonDerivative · entry 1

TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · Director · 10% owner

TPG Advisors VI, Inc. · CIK 0001433038 · Director · 10% owner

TPG Advisors V, Inc. · CIK 0001425876 · Director · 10% owner

TPG Biotech Advisors, Inc. · CIK 0001666545 · Director · 10% owner

BONDERMAN DAVID · CIK 0000860866 · Director · 10% owner

COULTER JAMES G · CIK 0001099776 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 42,090,544

F1 · ownership.nature: David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. ("Group Advisors"), (ii) TPG Advisors VI, Inc. ("Advisors VI"), (iii) TPG Advisors V, Inc. ("Advisors V") and (iv) TPG Biotech Advisors, Inc. ("Biotech Advisors" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the "Reporting Persons").

F2 · ownership.nature: Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 15,051,563 shares of Common Stock ("Common Stock") of Quintiles IMS Holdings, Inc. (the "Issuer"), (ii) TPG FOF V-A, L.P., which directly holds 39,375 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 31,750 shares of Common Stock.

F3 · ownership.nature: TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 15,063,142 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 621,480 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 59,545 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 5,179,003 shares of Common Stock.

F4 · ownership.nature: Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 5,744,110 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the "TPG Funds"), which directly holds 300,576 shares of Common Stock.

F5 · ownership.nature: Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any.

F6 · ownership.nature: The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the "Shareholders Agreement"), with certain other holders (the "Holders") of shares of Common Stock. Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), to beneficially own the shares of Common Stock held in the aggregate by the Holders. Each Reporting Person and each TPG Fund disclaims beneficial ownership of the shares of Common Stock held by the Holders.

F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

SEC source: 0001209191-17-016516 · doc4.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 6,214,802

F1 · shares: 852,550 shares of common stock, par value $0.01 per share, of the Issuer (the "Shares") were sold by Green Equity Investors V, L.P. ("GEI V"), 255,745 Shares were sold by Green Equity Investors Side V, L.P. ("GEI Side V"), and 8,112 Shares were sold by by LGP Iceberg Coinvest, LLC ("LGP Ice").

F2 · balance_after: 4,745,966 Shares are owned by GEI V, 1,423,675 Shares are owned by GEI Side V, and 45,161 Shares are owned by LGP Ice.

F3 · ownership.nature: Mr. Danhakl directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares owned by GEI V, GEI Side V and LGP Ice. Mr. Danhakl disclaims beneficial ownership of the Shares reported herein except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC source: 0001478242-17-000007 · edgar.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,034

Underlying: Common Stock · 26,034 shares

Expires 2027-02-02

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018.

SEC source: 0001478242-17-000002 · edgar.xml · derivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,224

Underlying: Common Stock · 18,224 shares

Expires 2027-02-02

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018.

SEC source: 0001478242-17-000006 · edgar.xml · derivative · entry 1

Erlinger III James H · CIK 0001575957 · Exec VP and GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,318

Underlying: Common Stock · 14,318 shares

Expires 2027-02-02

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018.

SEC source: 0001478242-17-000005 · edgar.xml · derivative · entry 3

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,206

Underlying: Common Stock · 156,206 shares

Expires 2027-02-02

F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018.

SEC source: 0001478242-17-000005 · edgar.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 990,759

F1 · shares: Represents a grant of restricted stock received as an award under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan, for no consideration, and exempt pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. The restricted stock will vests 25% on February 2, 2019, 25% on February 2, 2020 and 50% on February 2, 2021.

SEC source: 0001478242-17-000004 · edgar.xml · derivative · entry 1

Williams Charles Edward · CIK 0001376911 · Sr VP and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,508

Underlying: Common Stock · 6,508 shares

Expires 2027-02-02

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018.

SEC source: 0001478242-17-000003 · edgar.xml · derivative · entry 1

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,224

Underlying: Common Stock · 18,224 shares

Expires 2027-02-02

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018.

SEC source: 0001478242-16-000014 · edgar.xml · nonDerivative · entry 1

Williams Charles Edward · CIK 0001376911 · Sr VP and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,771

F1 · shares: Reflects shares withheld for taxes upon the vesting of 366 RSUs on December 19, 2016.

F2 · balance_after: This amount includes 742 RSUs granted on December 19, 2013, 722 RSUs granted on March 4, 2015 and 1,933 RSUs granted on March 3, 2016.

SEC source: 0001478242-16-000013 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,767

F1 · shares: Reflects shares withheld for taxes upon the vesting of 9,094 RSUs on December 16, 2016.

F2 · balance_after: This amount includes 27,280 RSUs granted on December 16, 2015, and 7,732 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.

SEC source: 0001478242-16-000007 · edgar.xml · nonDerivative · entry 1

Erlinger III James H · CIK 0001575957 · Exec VP and GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,622

F1 · shares: Reflects shares withheld for taxes upon the vesting of 1,149 RSUs on November 24, 2016.

F2 · balance_after: This amount includes 2,331 RSUs granted on November 24, 2013, 2,600 RSUs granted on May 12, 2014, 5,759 RSUs converted on October 3, 2016 from PUs orginially issued to the reporting person on March 4, 2015 and 6,185 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.

SEC source: 0001478242-16-000006 · edgar.xml · derivative · entry 4

GREENBERG JACK M · CIK 0001074611 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,092

Underlying: Common Stock · 2,000 shares

Expires 2018-06-01

F1 · ownership.nature: The shares are held for the benefit of members of the reporting person's family. The reporting person may be deemed to have voting and dispositive power over the shares held for the benefit of members of his family. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001478242-16-000006 · edgar.xml · nonDerivative · entry 2

GREENBERG JACK M · CIK 0001074611 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 25,000

F1 · ownership.nature: The shares are held for the benefit of members of the reporting person's family. The reporting person may be deemed to have voting and dispositive power over the shares held for the benefit of members of his family. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001478242-16-000006 · edgar.xml · nonDerivative · entry 1

GREENBERG JACK M · CIK 0001074611 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 27,000

F1 · ownership.nature: The shares are held for the benefit of members of the reporting person's family. The reporting person may be deemed to have voting and dispositive power over the shares held for the benefit of members of his family. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001209191-16-144306 · doc4.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,106

F1 · security: Issuance to the reporting person of restricted stock units ("RSUs") under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) upon the conversion, at the effective time of the merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc., of performance units ("PUs") originally issued to the reporting person on March 3, 2016. The PUs converted into RSUs at 100% of target, and the resulting RSUs will vest in full on December 31, 2018, the end of the original performance period of the PUs that were converted.

F2 · balance_after: This amount includes 36,374 RSUs granted on December 16, 2015 and 7,732 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.

SEC source: 0001209191-16-144113 · doc4.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,331,209

F1 · shares: The shares of common stock, par value $0.01 per share, of the Issuer (the "Shares") were acquired in the merger (the "Merger") of IMS Health Holdings, Inc. ("IMS") with and into Quintiles IMS Holdings, Inc. (the "Issuer") pursuant to the Agreement and Plan of Merger, dated May 3, 2016, by and between IMS and the Issuer (the "Merger Agreement"). Upon consummation of the Merger, each share of IMS common stock was automatically converted into the right to receive 0.3840 of a Share, calculated in accordance with the Merger Agreement and subject to the adjustment procedures set forth in the Merger Agreement. Of the Shares reported on this row, 5,598,516 Shares are owned by Green Equity Investors V, L.P. ("GEI V"), 1,679,420 Shares are owned by Green Equity Investors Side V, L.P. ("GEI Side V"), and 53,273 Shares are owned by LGP Iceberg Coinvest, LLC ("LGP Ice").

F2 · ownership.nature: Mr. Danhakl directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares owned by GEI V, GEI Side V and LGP Ice. Mr. Danhakl disclaims beneficial ownership of the Shares reported herein except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC source: 0001209191-16-144297 · doc4.xml · nonDerivative · entry 2

Erlinger III James H · CIK 0001575957 · Exec VP and GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,024

F3 · security: Issuance to the reporting person of RSUs under the Plan upon the conversion, at the effective time of the Merger, of PUs originally issued to the reporting person on March 3, 2016. The PUs converted into RSUs at 100% of target, and the resulting RSUs will vest in full on December 31, 2018, the end of the original performance period of the PUs that were converted.

F4 · balance_after: This amount includes 3,480 RSUs granted on November 24, 2013, 2,600 RSUs granted on May 12, 2014, 5,759 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015 and 6,185 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.

SEC source: 0001209191-16-144297 · doc4.xml · nonDerivative · entry 1

Erlinger III James H · CIK 0001575957 · Exec VP and GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,839

F1 · security: Issuance to the reporting person of restricted stock units ("RSUs") under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) (the "Plan") upon the conversion, at the effective time of the merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc. (the "Merger"), of performance units ("PUs") originally issued to the reporting person on March 4, 2015. The PUs converted into RSUs at 187% of target, and the resulting RSUs will vest in full on December 31, 2017, the end of the original performance period of the PUs that were converted.

F2 · balance_after: This amount includes 3,480 RSUs granted on November 24, 2013, 2,600 RSUs granted on May 12, 2014 and 5,759 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015.

SEC source: 0001209191-16-144322 · doc4.xml · nonDerivative · entry 3

Pike Thomas · CIK 0001471570 · Director · Vice Chair, Pres R&D Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,460

F5 · security: Issuance to the reporting person of RSUs under the Plan upon the conversion, at the effective time of the Merger, of PUs originally issued to the reporting person on March 3, 2016. The PUs converted into RSUs at 100% of target, and the resulting RSUs will vest in full on December 31, 2018, the end of the original performance period of the PUs that were converted.

F6 · balance_after: This amount includes 86,356 shares of restricted stock granted on September 30, 2016, 18,000 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015 and 42,524 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.

SEC source: 0001209191-16-144322 · doc4.xml · nonDerivative · entry 2

Pike Thomas · CIK 0001471570 · Director · Vice Chair, Pres R&D Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,936

F3 · security: Issuance to the reporting person of restricted stock units ("RSUs") under the Plan upon the conversion, at the effective time of the merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc. (the "Merger"), of performance units ("PUs") originally issued to the reporting person on March 4, 2015. The PUs converted into RSUs at 187% of target, and the resulting RSUs will vest in full on December 31, 2017, the end of the original performance period of the PUs that were converted.

F4 · balance_after: This amount includes 86,356 shares of restricted stock granted on September 30, 2016 and 18,000 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015.

SEC source: 0000903423-16-001293 · tpgsbq4.xml · nonDerivative · entry 1

TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · 10% owner

TPG Advisors VI, Inc. · CIK 0001433038 · 10% owner

TPG Advisors V, Inc. · CIK 0001425876 · 10% owner

TPG Biotech Advisors, Inc. · CIK 0001666545 · 10% owner

BONDERMAN DAVID · CIK 0000860866 · 10% owner

COULTER JAMES G · CIK 0001099776 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 49,651,557

F1 · kind: The securities reported herein were acquired pursuant to the Agreement and Plan of Merger, dated as of May 3, 2016 (the "Merger Agreement"), by and among IMS Health Holdings, Inc. ("IMS") and Quintiles Transnational Holdings Inc. (the "Issuer"), whereby IMS merged with and into the Issuer with the Issuer surviving the merger (the "Merger"). At the effective time of the Merger, each share of Common Stock of IMS (the "IMS Shares"), issued and outstanding immediately prior to such time (other than IMS Shares held by IMS in treasury or owned by the Issuer or any of their direct or indirect subsidiaries) was cancelled and ceased to exist and was converted into the right to receive 0.3840 of validly issued, fully paid and non-assessable shares of Common Stock of the Issuer, par value $0.01 per share (the "Issuer Shares").

F1 · price: The securities reported herein were acquired pursuant to the Agreement and Plan of Merger, dated as of May 3, 2016 (the "Merger Agreement"), by and among IMS Health Holdings, Inc. ("IMS") and Quintiles Transnational Holdings Inc. (the "Issuer"), whereby IMS merged with and into the Issuer with the Issuer surviving the merger (the "Merger"). At the effective time of the Merger, each share of Common Stock of IMS (the "IMS Shares"), issued and outstanding immediately prior to such time (other than IMS Shares held by IMS in treasury or owned by the Issuer or any of their direct or indirect subsidiaries) was cancelled and ceased to exist and was converted into the right to receive 0.3840 of validly issued, fully paid and non-assessable shares of Common Stock of the Issuer, par value $0.01 per share (the "Issuer Shares").

F2 · ownership.nature: David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. ("Group Advisors"), (ii) TPG Advisors VI, Inc. ("Advisors VI"), (iii) TPG Advisors V, Inc. ("Advisors V") and (iv) TPG Biotech Advisors, Inc. ("Biotech Advisors" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the "Reporting Persons").

F3 · ownership.nature: Group Advisors is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 17,755,378 Issuer Shares, (ii) TPG FOF V-A, L.P., which directly holds 46,448 Issuer Shares, and (iii) TPG FOF V-B, L.P., which directly holds 37,454 Issuer Shares.

F4 · ownership.nature: TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 17,769,038 Issuer Shares. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 733,121 Issuer Shares. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 70,241 Issuer Shares, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 6,109,343 Issuer Shares.

F5 · ownership.nature: Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 6,775,964 Issuer Shares. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the "TPG Funds"), which directly holds 354,570 Issuer Shares.

F6 · ownership.nature: Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any.

F7 · ownership.nature: The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the "Shareholders Agreement"), with certain other holders (the "Holders") of Issuer Shares. Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), to beneficially own the Issuer Shares held in the aggregate by the Holders. Each Reporting Person and each TPG Fund disclaims beneficial ownership of the Issuer Shares held by the Holders.

F8 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

SEC source: 0001209191-16-145007 · doc4.xml · derivative · entry 4

Rittenmeyer Ronald A · CIK 0001210018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,680

Underlying: Common Stock · 7,680 shares

Expires 2020-07-20

F5 · price: Received in the Merger in exchange for a stock option to acquire 20,000 shares of IMS Health common stock for $3.20 per share.

SEC source: 0001209191-16-145007 · doc4.xml · derivative · entry 3

Rittenmeyer Ronald A · CIK 0001210018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,840

Underlying: Common Stock · 3,840 shares

Expires 2020-07-20

F4 · price: Received in the Merger in exchange for a stock option to acquire 10,000 shares of IMS Health common stock for $5.80 per share.

SEC source: 0001209191-16-145007 · doc4.xml · derivative · entry 2

Rittenmeyer Ronald A · CIK 0001210018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,680

Underlying: Common Stock · 7,680 shares

Expires 2020-07-20

F3 · price: Received in the Merger in exchange for a stock option to acquire 20,000 shares of IMS Health common stock for $10.00 per share.

SEC source: 0001209191-16-145007 · doc4.xml · nonDerivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,849

F1 · price: On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share.

F2 · price: Received in exchange for 142,840 shares of IMS Health common stock and restricted stock units in connection with the Merger.

SEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 7

Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,566

Underlying: Common Stock · 18,566 shares

Expires not disclosed

F10 · derivative.exercise_price: Represents notional shares held under the Quintiles IMS Holdings, Inc. Defined Contribution Executive Retirement Plan payable upon the reporting person's termination of employment.

F1 · price: On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share.

F11 · price: Received in the Merger in exchange for a notional share to purchase 48,349 shares of IMS Health common stock.

F10 · derivative.exercise_date: Represents notional shares held under the Quintiles IMS Holdings, Inc. Defined Contribution Executive Retirement Plan payable upon the reporting person's termination of employment.

F10 · derivative.expiration_date: Represents notional shares held under the Quintiles IMS Holdings, Inc. Defined Contribution Executive Retirement Plan payable upon the reporting person's termination of employment.

SEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 6

Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,207

Underlying: Common Stock · 10,207 shares

Expires 2026-02-02

F9 · price: Received in the Merger in exchange for a stock appreciation right to acquire 26,581 shares of IMS Health common stock for $23.00 per share.

F8 · derivative.exercise_date: This stock appreciation right vests in four annual installments beginning on February 2, 2017.

SEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 5

Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,284

Underlying: Common Stock · 8,284 shares

Expires 2025-02-10

F7 · price: Received in the Merger in exchange for a stock appreciation right to acquire 21,574 shares of IMS Health common stock for $25.02 per share.

F6 · derivative.exercise_date: This stock appreciation right vests in four annual installments, with the first installment having vested on February 10, 2016 and the remaining three installments vesting on February 10, 2017, 2018 and 2019.